tirzepatide mechanism of action Unveiling Tirzepatide's Therapeutic Spectrum: A Dual GIP/GLP-1 Agonist Targeting Metabolic, Neurological, and Cardiovascular Health Tirzepatide - an overview |

While alopecia is not listed among the adverse reactions in the FDA-approved prescribing information for Ozempic, it is documented in the Wegovy label as occurring at a low frequency and more often than placebo

Key takeaways Mounjaro is a GLP-1 medication that also acts on GIP receptors to regulate blood sugar levels

Dental sealants Sealants create a protective barrier over teeth, shielding them from bacteria and decay

It enables informed decision-making and a patient-centered approach to weight management

[2] Similarly, the SURMOUNT trials examining tirzepatide for weight management did not report lymphadenopathy as a treatment-emergent adverse event